OUTCOME OF TREATMENT DISCONTINUATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AND NO EVIDENCE OF DISEASE FOLLOWING TARGETED THERAPY WITH OR WITHOUT METASTASECTOMY Article Johannsen M., Miller K., Weikert S., Staehler M., Ohlmann C.H., Flörcken A., Schmittel A., Otto T., Bex A., Hein P., Grünwald V. Annals of Oncology. Oxford University Press. Vol. 22. 2011. P. 657-663
